Primary Record
Rifamycin SV
- In stock
- 4,402 g
- Purity
- 99.0 %
- CAS
- 6998-60-3
Compound Identifiers & Properties
- CAS
- 6998-60-3
- PubChem CID
- 6324616
- SMILES
- C[C@H]1/C=C/C=C(\C(=O)NC2=CC(=C3C(=C2O)C(=C(C4=C3C(=O)[C@](O4)(O/C=C/[C@@H]([C@H]([C@H]([C@@H]([C@@H]([C@@H]([C@H]1O)C)O)C)OC(=O)C)C)OC)C)C)O)O)/C
- Canonical SMILES
- CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(cc(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C
Names & Synonyms
- Rifamycin SV
- RIFAMYCIN
- Rifocin
- Rifamicine SV
- Rifomycin SV
- Rifamicina
- Rifamycine
- Rifamycinum
- Rifocyn
- Rifamycins
- Rifomycins
- Aemcolo
- Rifacin
- Rifocina
- Rifocyna
- Rifogal
- Tuborin
- Otafa
- rifamycin-sv
- Rifamycine Chibret
- RIFOMYCIN
- Rifamicina Colirio
- Rifamycin SV MMX
- Sodium rifomycin SV
- Monosodium rifamycin SV
- Rifamycine [INN-French]
- Rifamycinum [INN-Latin]
- DU69T8ZZPA
- Rifamycin sodium salt
- Rifamicina [INN-Spanish]
- 6998-60-3
- Rifaximin EP Impurity C
- Rifamycin SV sodium salt
- RIFAMYCIN SODIUM
- UNII-DU69T8ZZPA
- 3-Methansulfinyl-phenol
- RefChem:57064
- RIFAMYCIN [INN]
- Rifamycin (USAN/INN)
- RIFAMYCIN [USAN]
- GlyTouCan:G97409XF
- Rifamycin [INN:BAN:DCF]
- rifamycin SV, sodium salt
- Rifamycin, monosodium salt
- DTXSID1032014
- D0FX2Q
- RIFAMYCIN SV [MI]
- RIFAMYCIN [WHO-DD]
- HJYYPODYNSCCOU-ODRIEIDWSA-N
- C37H47NO12
- Rifamycin [BAN:DCF:INN]
- CHEBI:29673
- CB-01-11
- rifamycin SV, monosodium salt
- SCHEMBL151824
- 6998-60-3 (free acid)
- EINECS 230-273-3
- C37H47NO12.Na
- Rifamycin [USAN:INN:BAN:DCF]
- CHEMBL437765
- GTPL4570
- DTXCID9012014
- SCHEMBL29355202
- SCHEMBL29649054
- CHEBI:26580
- HY-B1907A
- A07AA13
- D06AX15
- J04AB03
- S02AA12
- 29),26-octaen-13-yl acetate
- NSC133100
- GLXC-20256
- M-14
- C37-H47-N-O12.Na
- RIFAMYCIN SV [EP IMPURITY]
- G97409XF
- 8248AH
- BBF-02634
- BDBM50391000
- LMPK05000005
- MFCD01741300
- AKOS024281286
- C37-H47-N-O12
- ZINC169633673
- CID6324616
- CS-O-02237
- DB11753
- LS-2172
- NSC 133100
- CID:6324616
- 15105-92-7
- SC-49540
- SID:53786745
- SID:53790785
- ST044225
- R-75-1
- RIFAXIMIN IMPURITY C [EP IMPURITY]
- 2841A
- CS-0092130
- FT-0701680
- First International Standard for Rifamycin SV
- C12044
- D02549
- A899902
- C023808
- D012294
- SR-01000872597
- SR-01000872597-1
- (pentahydroxy-methoxy-heptamethyl-dioxo-[?]yl) acetate
- Q26270990
- Rifamycin SV, an antibiotic produced by certain strains of Streptomyces mediterranei, or the same substance produced by any other means
- [(7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl] acetate
- 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-2,7-(epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2-H)-dione, 21-acetate
- Rifamycin (oral controlled-release, gastrointestinal-specific)
- (2S,12Z,14E,16S,17S,18R,19R,20R,21S,22R,23S,24E)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-1,11-dioxo-1,2-dihydro-2,7-(epoxypentadeca[1,11,13]trienoimino)naphtho[2,1-b]furan-21-yl acetate
- (7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-Pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.14,7.05,28]triaconta-1(28),2,4,9,19,21,25(29),26-octaen-13-yl acetate
- 2,7-(Epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2H)-dione, 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-, 21-acetate
- 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-2,7-(Epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2H)-dione 21-acetate
- 2,7-(Epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan, rifamycin deriv.
- Rifamycin (oral controlled-release, gastrointestinal-specific), Cosmo/Dr Falk/Santarus
- ((7S,9E,11S,12R,13S,14R,15R,16R,17S,18S,19E,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo(23.3.1.14,7.05,28)triaconta-1(29),2,4,9,19,21,25,27-octaen-13-yl) acetate
- (7S,11S,12R,13S,14R,15R,16R,17S,18S,19Z,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo(23.3.1.1^(4,7).0^(5,28))triaconta-1,3,5(28),9,19,21,25(29),26-octaen-13-yl acetate
- (7S,11S,12R,13S,14R,15R,16R,17S,18S,19Z,21Z)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1^{4,7}.0^{5,28}]triaconta-1,3,5(28),9,19,21,25(29),26-octaen-13-yl acetate
- (7S,11S,13S,17S,18S,12R,14R,15R,16R)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7 ,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1<4, 7>.0<5,28>]triaconta-1(28),2,4,9,19,21,25(
- (7S,11S,13S,17S,18S,12R,14R,15R,16R)-2,15,17,27,29-pentahydroxy-11-methoxy-3,7 ,12,14,16,18,22-heptamethyl-6,23-dioxo-8,30-dioxa-24-azatetracyclo[23.3.1.1<4, 7>.0<5,28>]triaconta-1(28),2,4,9,19,21,25(29),26-octaen-13-yl acetate
- 2,7-(Epoxy[1,11,13]pentadecatrienoimino)naphtho[2,1-b]furan-1,11(2H)-dione, 21-(acetyloxy)-5,6,9,17,19-pentahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-, (2S,16S,17S,18R,19R,20R,21S,22R,23S)-
- 2,7-(Epoxypentadeca(1,11,13)trienimino)naphtho(2,1-b)furan-1,11(2H)-dione,5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-, 21-acetate
- 2,7-(Epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,11(2H)-dione, 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-, 21-acetate
- 2,7-(Epoxypentadeca[1,11,13]trienimino)naphtho[2,1-b]furan-1,11(2H)-dione, 5,6,9,17,19,21-hexahydroxy-23-methoxy-2,4,12,16,18,20,22-heptamethyl-, 21-acetate, monosodium salt
- 230-273-3